Thursday, January 23, 2025, 6.00pm PST to Saturday, April 5, 2025, 8.00pm PDT
Join us in Seattle for a special event to celebrate the 25th anniversary of the Gates Cambridge Scholarship. The evening will feature a conversation on global leadership and entrepreneurship between two distinguished Scholars from the Scholarship’s inaugural cohort.
Dr Andrew Robertson (2001), Vice President and Head of Global Regulatory Policy at Takeda, will moderate a discussion with Mohit Bhende (Trinity Hall, 2001), the co-founder of Karat, a groundbreaking enterprise that has revolutionized technical interviewing. Together, they will explore the challenges and opportunities of global leadership and entrepreneurship in today’s world.
Don’t miss this chance to hear from two exceptional leaders who have made a significant impact in their respective fields. Following the lecture will be a brief Q & A and time to network with fellow Gates Cambridge Scholars and Cambridge alumni over drinks and canapés.
We look forward to seeing you there!
Speaker Profiles
Mohit Bhende is CEO and Co-Founder of Karat, the world’s leading hiring solution for companies seeking top software engineering talent. Karat has conducted over 500,000 technical interviews and operates as a bar-raising partner for global enterprises like Atlassian, Citi, and Schlumberger as they improve hiring speed and quality. Karat became one of Seattle's tech unicorns after reaching a $1.1B valuation in its most recent funding round. The company also raised a strategic investment from tennis champion Serena Williams to help scale its Brilliant Black Minds program, which provides free technical interview practice for Black software engineers in the U.S. In 2023, Karat announced the acquisition of San Francisco-based Triplebyte, with several subsequent acquisitions of AI technology and talent from around the world.
Andrew Robertson is the Vice President and Head of Global Regulatory Policy and Innovation at Takeda. He has leveraged his expertise in science, law, and policy to advance global healthcare innovation and improve patient access to medicines. In his current role, Andrew oversees Takeda R&D's global regulatory policy activities, affecting pre-clinical and clinical development, regulatory approval, and post-market strategy. He has spearheaded multiple strategic initiatives combining digital, AI, and data-driven approaches to regulatory contexts.
Before joining Takeda, Andrew held roles in industry, academia, and government, including Digital and Data Strategy Head for Sanofi R&D, Faculty Researcher at the UK Wellcome Trust Sanger Institute, and Science Policy Advisor for the Health and Human Services Office of Preparedness and Response. His recent first-author publications include discussions on cloud-based platforms in regulatory affairs (Nature Reviews, 2020), data-driven regulatory intelligence (Nature Reviews, 2021), and the importance of regulatory predictability (JAMA, 2023). He holds a JD from UC Berkeley School of Law and a PhD in Structural Biochemistry from the University of Cambridge, where he was a Gates Cambridge Scholar.
